Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)

被引：1
|
作者：
Papadaki, M. A. [1 ]
Kapetanaki, E-E. [1 ]
Vorrias, E. [2 ]
Mavroudis, D. [3 ]
Agelaki, S. [3 ]
机构：
[1] UOC Univ Crete, Lab Translat Oncol, Sch Med, Iraklion, Greece
[2] Univ Gen Hosp Herakl, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Univ Gen Hosp Heraklion, Sch Med, Dept Med Oncol,Lab Translat Oncol, Iraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1653P
引用
收藏
页码：S1166 / S1166
页数：1
相关论文
共 50 条
  • [1] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [2] The expression and analysis of PD-L1 in peripheral blood circulating tumor cells of lung cancer
    Wang, Wei
    Zhang, Tao
    [J]. FUTURE ONCOLOGY, 2021, 17 (13) : 1625 - 1635
  • [3] Monitoring of PD-L1 expression on circulating immune cells of patients with small cell lung cancer (SCLC) receiving firstline treatment: Prognostic implications
    Papadaki, M. A.
    Nikolarakou, M-N.
    Vorrias, E.
    Kapetanaki, E-E.
    Kalapanida, D.
    Mavroudis, D.
    Agelaki, S.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S101 - S101
  • [4] PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas
    Ilie, Marius
    Hofman, Veronique
    Long, Elodie
    Butori, Catherine
    Lalvee, Salome
    Selva, Eric
    Venissac, Nicolas
    Mouroux, Jerome
    Marquette, Charles Hugo
    Hofman, Paul
    [J]. CANCER RESEARCH, 2016, 76
  • [5] A Novel Method for Detecting Surface PD-L1 on Circulating Tumor Cells in Peripheral Blood of Patients with SCLC
    Zhao, D.
    Li, H.
    Liu, Y.
    Liu, Y.
    Liu, J.
    Cheng, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1061 - S1061
  • [6] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    [J]. CANCER RESEARCH, 2016, 76
  • [7] Longitudinal investigation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
    Koh, Yasuhiro
    Ikeda, Mio
    Teraoka, Shunsuke
    Sato, Koichi
    Tokudome, Nahomi
    Hayata, Atsushi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Akamatsu, Keiichiro
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [8] Longitudinal evaluation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab
    Ikeda, Mio
    Koh, Yasuhiro
    Teraoka, Shunsuke
    Sato, Koichi
    Tokudome, Nahomi
    Hayata, Atsushi
    Akamatsu, Hiroaki
    Ozawa, Yuichi
    Akamatsu, Keiichiro
    Endo, Katsuya
    Higuchi, Masayuki
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 83 - 83
  • [9] Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy
    Krupa, Rachel
    Richardson, Robin
    Ontiveros, Priscilla
    Schonhoft, Joseph
    Byun, Jiyun
    Lu, David
    Nisperos, Sean
    Wang, Yipeng
    Landers, Mark
    Dittamore, Ryan
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [10] Characterization of programmed cell death-1 ligand (PD-L1) expression in circulating tumor cells (CTCs) of lung cancer
    Krupa, Rachel
    Lu, David
    Graf, Ryon
    Louw, Jessica
    Dugan, Lyndsey
    Jendrisak, Adam
    Bethel, Kelly
    Wang, Yipeng
    Marrinucci, Dena
    Dittamore, Ryan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S52 - S52
12345